Preterm birth, also known as premature birth, is the birth of a baby at fewer than 37 weeks gestational age. These babies are known as preemies or premies.
Prevalent preterm cases and the growing demand for cost effective diagnosis of preterm births at hospitals, outpatient clinics and diagnostic laboratories have increased the demand for preterm birth diagnostic test kits.

The global Preterm Birth Diagnostic Test Kits market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Preterm Birth Diagnostic Test Kits volume and value at global level, regional level and company level. From a global perspective, this report represents overall Preterm Birth Diagnostic Test Kits market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Preterm Birth Diagnostic Test Kits in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Preterm Birth Diagnostic Test Kits manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Qiagen
Medixbiochemica
Hologic
Sera Prognostics
IQ Products
Creative Diagnostics
Clinical Innovations
BIOSERV Diagnostics
Nanjing Liming Biological Preparations

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
fFN Test Kits
PAMG-1 Test Kits
IGFBP 1 Test Kits
Others

Segment by Application
Hospitals
Clinics
Diagnostic Laboratories
Others